Beleave(OTC) BLEVF

Market CapN/A

Since IPO (2016)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

Beleave last closing stock price
Metric	Price	Date
Last close	USD 0.00	2025-06-26

Beleave stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2025-05-16
1 month	+0%	USD 0.00	2025-05-16
3 month	+0%	USD 0.00	2025-03-20
Year to date	+0%	USD 0.00	2024-12-31
1 year	+0%	USD 0.00	2024-06-26
3 year	-90%	USD 0.00	2022-06-21
5 year	-99.96%	USD 0.00	2020-06-26
Since inception	-100%	USD 0.09	2016-09-28

Beleave Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$2.90M

Net Income (TTM)

-CA$15.87M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 29, 2018

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 29, 2018

BLEVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Beleave

Beleave Inc. is a Canadian medical cannabis enterprise based in Oakville, specializing in the cultivation and distribution of cannabis products for both medical and recreational use. The company also operates a network of medical cannabis clinics across Ontario and Quebec under the Medi-Green brand.

Products and Services

Cultivation of high-quality cannabis products
Distribution to medical and recreational markets
Management of Medi-Green medical cannabis clinics

Growth Outlook

Expansion of retail locations to enhance market presence
Increasing demand for medical cannabis products in Canada
Strategic partnerships to boost distribution capabilities

Financial Highlights

Recent quarterly revenue of CAD 381,943, showing potential for growth
Trailing twelve months (TTM) gross profit margin of 34.39%
Current ratio of 0.41 indicates liquidity challenges

Beleave Inc. operates in a rapidly evolving industry, with significant opportunities for growth as the demand for cannabis products continues to rise. The company's focus on both medical and recreational markets positions it well to capitalize on this trend. Recent financial data indicates a revenue of CAD 381,943 for the latest quarter, reflecting the potential for increased sales as the company expands its retail footprint. However, the current ratio of 0.41 suggests that liquidity may be a concern, necessitating careful management of resources. Overall, Beleave Inc. presents an intriguing opportunity for investors interested in the cannabis sector.

AI Generated • Jul 18, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Oakville, ON L6H 0H2, CA

BLEVF Financials

Key Financial Metrics (TTM)

Gross Margin

34.39%

Operating Margin

-989.32%

Net Income Margin

-1423.05%

Return on Equity

-341.61%

Return on Capital

-110.58%

Return on Assets

-143.10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-CA$4.94M

Operating Income

-CA$6.16M

EBITDA

-CA$7.34M

Operating Cash Flow

CA$8.77M

Capital Expenditure

-CA$3.21M

Free Cash Flow

CA$5.56M

Cash & ST Invst.

CA$120.41K

Total Debt

CA$12.37M

Beleave Performance Analysis

Beleave sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2019-03-31	29.3%
Q1	2019-06-30	-31.1%
Q2	2019-09-30	5.0%
Q3	2019-12-31	-49.4%

Beleave sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2019-03-31	-285.7%
Q1	2019-06-30	83.1%
Q2	2019-09-30	-84.4%
Q3	2019-12-31	20.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2019YOY CHG

Revenue

CA$381.94K

-52.7%

Gross Profit

-CA$908.22K

-163.6%

Gross Margin

-2.38%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-CA$2.49M

-13.6%

EBITDA

-CA$2.14M

+14.6%

Quarterly Fundamentals

Name

Q3 2019YOY CHG

Total Cash

CA$120.41K

-93.2%

Total Debt

CA$12.37M

+61.4%

Accounts Receivable

CA$267.29K

-80.8%

Inventory

CA$2.12M

-31.7%

Long Term Debt

CA$3.12M

+37.3%

Short Term Debt

CA$9.25M

+71.6%

Return on Assets

-1.43%

N/A

Return on Invested Capital

-1.77%

N/A

Free Cash Flow

CA$551.05K

+113.1%

Operating Cash Flow

CA$517.47K

+123.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MTEMMolecular Templates, Inc.

MTEMMolecular Templates, Inc.$0.00-0.00%

ARTHArch Therapeutics, Inc.

ARTHArch Therapeutics, Inc.$0.00+0.00%

MDKMMDEChem, Inc.

MDKMMDEChem, Inc.$0.00-100.00%

GNRSThe Greenrose Holding Company Inc.

GNRSThe Greenrose Holding Company Inc.$0.00-50.00%

MYHIMountain High Acquisitions Corp.

MYHIMountain High Acquisitions Corp.$0.00-99.00%

GRYNGreen Hygienics Holdings Inc.

GRYNGreen Hygienics Holdings Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.36+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.61-0.00%

INTCIntel

INTCIntel$102.95-0.02%

ONDSOndas

ONDSOndas$9.47+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$136.75-0.03%

CAPRCapricor Therapeutics

CAPRCapricor Therapeutics$6.46+0.54%

WETOWetour Robotics

WETOWetour Robotics$7.64+1.11%

Questions About BLEVF

What is the current price of Beleave?

Beleave is trading at N/A per share.

What is the 52-week range for Beleave?

Over the past 52 weeks, Beleave has traded between N/A and N/A.

How much debt does Beleave have?

Beleave total debt is unavailable.

How much cash does Beleave have on hand?

Beleave does not have cash on hand data available.

What is Beleave’s dividend yield?

Beleave does not currently have a dividend yield.

Beleave(OTC) BLEVF

Beleave Financials at a Glance

BLEVF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Beleave

BLEVF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Beleave Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BLEVF

What is the current price of Beleave?

What is the 52-week range for Beleave?

How much debt does Beleave have?

How much cash does Beleave have on hand?

What is Beleave’s dividend yield?

Premium Investing Services